My Quote Request
No products added yet
6505-01-057-1525
20 Products
NDC00182-1802-01
SALSALATE TABLETS,USP
NSN, MFG P/N
6505010571525
NSN
6505-01-057-1525
NDC00182-1802-01
SALSALATE TABLETS,USP
NSN, MFG P/N
6505010571525
NSN
6505-01-057-1525
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SALSALATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALSALATE TABLETS 500 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00089-0149-10
SALSALATE TABLETS,USP
NSN, MFG P/N
6505010571525
NSN
6505-01-057-1525
NDC00089-0149-10
SALSALATE TABLETS,USP
NSN, MFG P/N
6505010571525
NSN
6505-01-057-1525
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SALSALATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALSALATE TABLETS 500 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
IMFERON
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505010575458
NSN
6505-01-057-5458
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS IRON EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: EACH ML CONTAINS THE EQUIVALENT OF 50 MG OF IRON
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 2
Related Searches:
NDC00068-0052-22
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505010575458
NSN
6505-01-057-5458
NDC00068-0052-22
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505010575458
NSN
6505-01-057-5458
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS IRON EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: EACH ML CONTAINS THE EQUIVALENT OF 50 MG OF IRON
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 2
Related Searches:
ISORDIL TITRADOSE TABLETS
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505010576394
NSN
6505-01-057-6394
ISORDIL TITRADOSE TABLETS
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505010576394
NSN
6505-01-057-6394
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00008-4153-01
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505010576394
NSN
6505-01-057-6394
NDC00008-4153-01
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505010576394
NSN
6505-01-057-6394
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00082-4153-01
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505010576394
NSN
6505-01-057-6394
NDC00082-4153-01
ISOSORBIDE DINITRATE TABLETS,USP
NSN, MFG P/N
6505010576394
NSN
6505-01-057-6394
MFG
IVES LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ALPHA-KERI
MINERAL OIL,LANOLATED,WATER-DISPERSIBLE
NSN, MFG P/N
6505010576396
NSN
6505-01-057-6396
ALPHA-KERI
MINERAL OIL,LANOLATED,WATER-DISPERSIBLE
NSN, MFG P/N
6505010576396
NSN
6505-01-057-6396
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
ADMINISTRATION: TOPICAL
PHARMACEUTICAL VEHICLE TYPE: MINERAL OIL
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC0072-3600-04
MINERAL OIL,LANOLATED,WATER-DISPERSIBLE
NSN, MFG P/N
6505010576396
NSN
6505-01-057-6396
NDC0072-3600-04
MINERAL OIL,LANOLATED,WATER-DISPERSIBLE
NSN, MFG P/N
6505010576396
NSN
6505-01-057-6396
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
ADMINISTRATION: TOPICAL
PHARMACEUTICAL VEHICLE TYPE: MINERAL OIL
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
DIAPID
LYPRESSIN NASAL SOLUTION,USP
NSN, MFG P/N
6505010577410
NSN
6505-01-057-7410
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ADMINISTRATION: NASAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, SQUEEZE SPRAY
SPECIAL FEATURES: EACH ML CONTAINS A PRESSOR ACTIVITY EQUIVALENT TO 50 USP POSTERIOR PITUITY UNITS; FOR USE IN THE TREATMENT OF DIABETES INSIPIDUS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00078-0042-38
LYPRESSIN NASAL SOLUTION,USP
NSN, MFG P/N
6505010577410
NSN
6505-01-057-7410
NDC00078-0042-38
LYPRESSIN NASAL SOLUTION,USP
NSN, MFG P/N
6505010577410
NSN
6505-01-057-7410
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ADMINISTRATION: NASAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, SQUEEZE SPRAY
SPECIAL FEATURES: EACH ML CONTAINS A PRESSOR ACTIVITY EQUIVALENT TO 50 USP POSTERIOR PITUITY UNITS; FOR USE IN THE TREATMENT OF DIABETES INSIPIDUS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
ATIVAN
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
MFG
BTA PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORZAEPAM TABLETS 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00228-2059-10
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
NDC00228-2059-10
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
MFG
ACTAVIS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORZAEPAM TABLETS 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00781-1404-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
NDC00781-1404-01
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORZAEPAM TABLETS 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC64455-0064-10
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
NDC64455-0064-10
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010579846
NSN
6505-01-057-9846
MFG
BTA PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORZAEPAM TABLETS 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
F0029637421
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
F0029637421
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML PIGGYBACK VIAL
Related Searches:
NAFCIL
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML PIGGYBACK VIAL
Related Searches:
NALLPEN
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
MFG
KING PHARMACEUTICALS INC
Description
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML PIGGYBACK VIAL
Related Searches:
NDC00008-0431-14
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
NDC00008-0431-14
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML PIGGYBACK VIAL
Related Searches:
NDC00015-7226-95
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
NDC00015-7226-95
NAFCILLIN FOR INJECTION,USP
NSN, MFG P/N
6505010580075
NSN
6505-01-058-0075
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML PIGGYBACK VIAL
